Literature DB >> 10417389

Role of bacterial intimin in colonic hyperplasia and inflammation.

L M Higgins1, G Frankel, I Connerton, N S Gonçalves, G Dougan, T T MacDonald.   

Abstract

Enteropathogenic Escherichia coli (EPEC) cells adhere to gut epithelial cells through intimin alpha: the ligand for a bacterially derived epithelial transmembrane protein called the translocated intimin receptor. Citrobacter rodentium colonizes the mouse colon in a similar fashion and uses a different intimin: intimin beta. Intimin alpha was found to costimulate submitogenic signals through the T cell receptor. Dead intimin beta+ C. rodentium, intimin alpha-transfected C. rodentium or E. coli strain K12, and EPEC induced mucosal hyperplasia identical to that caused by C. rodentium live infection, as well as a massive T helper cell-type 1 immune response in the colonic mucosa. Mutation of cysteine-937 of intimin to alanine reduced costimulatory activity in vitro and prevented immunopathology in vivo. The mucosal changes elicited by C. rodentium were interferon-gamma-dependent. Immunopathology induced by intimin enables the bacteria to promote conditions that are favorable for increased microbial colonization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417389     DOI: 10.1126/science.285.5427.588

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  54 in total

1.  Microbe-host interactions in the alimentary tract: the gateway to understanding inflammatory bowel disease.

Authors:  N French; S Pettersson
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

Review 2.  The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.

Authors:  G Dougan; M Ghaem-Maghami; D Pickard; G Frankel; G Douce; S Clare; S Dunstan; C Simmons
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

Review 3.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Binding of intimin from enteropathogenic Escherichia coli to lymphocytes and its functional consequences.

Authors:  Nathalie S Gonçalves; Christine Hale; Gordon Dougan; Gad Frankel; Thomas T MacDonald
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella.

Authors:  Sara E Jones; Katherine L Knight
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

6.  Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.

Authors:  Chien-Chang Chen; Steve Louie; Beth McCormick; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 7.  Adherence of diarrheagenic Escherichia coli strains to epithelial cells.

Authors:  Alfredo G Torres; Xin Zhou; James B Kaper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

8.  Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits.

Authors:  Karina Ramirez; Rocio Huerta; Eric Oswald; Carlos Garcia-Tovar; Jose Manuel Hernandez; Fernando Navarro-Garcia
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

9.  Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis.

Authors:  Meiqian Weng; Deke Huntley; I-Fei Huang; Ondulla Foye-Jackson; Lijian Wang; Aliese Sarkissian; Qingping Zhou; W Allan Walker; Bobby J Cherayil; Hai Ning Shi
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

10.  Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.

Authors:  Kirk S B Bergstrom; Julian A Guttman; Mohammad Rumi; Caixia Ma; Saied Bouzari; Mohammed A Khan; Deanna L Gibson; A Wayne Vogl; Bruce A Vallance
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.